Stable Isotopes Product Detail
Home Stable Isotopes CS-T-100978

BAY 60-6583-13C2,15N

Chemical Properties and Information

Product Code: CS-T-100978 Stable Isotopes
BAY 60-6583-13C2,15N
API Family
--
Product Code
CS-T-100978

BAY 60-6583-13C2,15N

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-100978
CAS No.
--
Molecular Formula
C17¹³C2H17N4¹5NO2S
Molecular Weight
382.41
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-100978
M.F.
C17¹³C2H17N4¹5NO2S
M.W.
382.41
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"BAY 60-6583-13C2,15N"
References
"Baraldi, P.G. et al.: Purin. Signal., 4, 287 (2008); Eckle, T. et al.: Ciculation, 115, 1571 (2007); Eckle, T. et al.: J. Clin. Invest., 118, 3301 (2008);"
Synonyms
"2-[[6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]-2-pyridinyl]thio]acetamide-13C2,15N; BR 4887-13C2,15N;"
Application Notes
Isotope labelled BAY 60-6583 is a potent and selective adenosine A2B receptor agonist. BAY 60-6583 shows protective effects against ischemia in both the heart and kidney in animal models. BAY 60-6583 is also a useful therapeutic drug in the treatment of acute lung injury.
Hazard Compound
Refer MSDS for complete information.
Overview
Isotope labelled BAY 60-6583 is a potent and selective adenosine A2B receptor agonist. BAY 60-6583 shows protective effects against ischemia in both the heart and kidney in animal models. BAY 60-6583 is also a useful therapeutic drug in the treatment of acute lung injury.
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.